J.L. Chin

1.3k total citations · 1 hit paper
8 papers, 966 citations indexed

About

J.L. Chin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J.L. Chin has authored 8 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in J.L. Chin's work include Prostate Cancer Treatment and Research (3 papers), Bone health and treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). J.L. Chin is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Bone health and treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). J.L. Chin collaborates with scholars based in Canada, United States and Ireland. J.L. Chin's co-authors include Simon Tchekmedyian, Louis Lacombe, J. Vinholes, J. A. Goas, Ann Thomas, M. Jabed Seraj, Dan Theodorescu, Hassan Razvi, Deirdre O’Riordan and Bernard Silke and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J.L. Chin

7 papers receiving 935 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

2004 891 citations Simon Tchekmedyian, Louis Lacombe et al. JNCI Journal of the National Cancer Institute profile →

Peers

J.L. Chin

ONCOL

PRM

RNMI

SURGE

OSM

P. Venner Canada

G.H. Urwin United Kingdom

Clive Sinoff Canada

Leo V. Lacerna United States

Richard Leff United States

M. Bonsignori Italy

T. Taube Finland

Gerard Powell Australia

Silvana Spadafora Canada

S. Houston United Kingdom

P. Venner Canada

J.L. Chin

1.1k ×1.4

ONCOL

887 ×1.5

PRM

520 ×1.4

RNMI

237 ×1.1

SURGE

209 ×1.6

OSM

Citations per year, relative to J.L. Chin J.L. Chin (= 1×) peers P. Venner

Countries citing papers authored by J.L. Chin

Since Specialization

Citations

This map shows the geographic impact of J.L. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Chin more than expected).

Fields of papers citing papers by J.L. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Chin. The network helps show where J.L. Chin may publish in the future.

Co-authorship network of co-authors of J.L. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Chin. A scholar is included among the top collaborators of J.L. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Chin. J.L. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Brett, Sabine, et al.. (2015). Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer. Prostate Cancer and Prostatic Diseases. 18(3). 213–220. 9 indexed citations

2.

Chin, J.L., Seán O’Dowd, Wan Ahmad Hafiz Wan Md Adnan, et al.. (2011). Using the MDRD value as an outcome predictor in emergency medical admissions. Nephrology Dialysis Transplantation. 26(10). 3155–3159. 14 indexed citations

3.

Venkatesan, V., et al.. (2007). Comparison of Health Related Quality of Life (HRQOL) in Men Treated With Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 69(3). S28–S28.

4.

Tchekmedyian, Simon, et al.. (2004). Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer. JNCI Journal of the National Cancer Institute. 96(11). 879–882. 891 indexed citations breakdown →

5.

Chin, J.L., Fred Saad, Donald M. Gleason, et al.. (2004). Clinical benefit of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer based on history of skeletal complications. Journal of Clinical Oncology. 22(14_suppl). 4576–4576. 5 indexed citations

6.

Razvi, Hassan, et al.. (2003). Malignancy in horseshoe kidneys: review and discussion of surgical implications.. PubMed. 10(3). 1899–904. 18 indexed citations

7.

Seraj, M. Jabed, Ann Thomas, J.L. Chin, & Dan Theodorescu. (2001). Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.. PubMed. 7(6). 1516–22. 23 indexed citations

8.

Levin, M F, Peter L. Munk, A D Vellet, & J.L. Chin. (1994). Self‐contained, inflatable penile prosthesis: Magnetic resonance appearance. Australasian Radiology. 38(1). 51–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact